Concentra Beats Q2, Lifts 2026 Outlook, and Maps CEO Transition
CON sits 65% above its 52-week low of $18.545.
Summary
Concentra posted better-than-expected Q2 2026 results, raised its full-year guidance, and detailed a CEO succession plan set for November 1, 2026.
Key Events · Earnings and Guidance · CON
-
Q2 Earnings Beat
Revenue grew 10.0% YoY to $606.0M, net income rose 45.7% to $67.3M, and Adjusted EBITDA increased 22.5% to $140.9M, with margin expansion of 237 bps.
-
Raised FY 2026 Guidance
Management raised revenue guidance to $2.325B-$2.375B, Adjusted EBITDA to $485M-$495M, and Free Cash Flow to $220M-$240M, reflecting strong operational momentum.
-
CEO Succession Announced
Keith Newton will step down as CEO effective November 1, 2026, transitioning to Executive Chairman. President and CFO Matthew DiCanio will become President and CEO and join the Board.
-
Chairman Role Change
Robert Ortenzio will resign as Chairman of the Board effective November 1, 2026, but will remain a director.
Analysis · CON · Industrial Applications And Services
A strong second quarter saw revenue climb 10% to $606M and net income jump 46% to $67.3M, fueled by volume gains and expanding margins. Bolstered by that momentum, management raised its full-year targets for revenue, Adjusted EBITDA, and free cash flow. At the same time, the company laid out a planned CEO handoff: Keith Newton will step down in November to become Executive Chairman, while President and CFO Matthew DiCanio ascends to the CEO role. The orderly succession and robust results underscore operational stability, though the open CFO seat introduces a near-term item to watch.
At the time of this filing, CON was trading at $30.54 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $18.55 to $32.86. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.